Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag…
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute fever-causing illnesses.Full automation facilitates medium to high throughput and enables improvement of lab efficiency and test traceability, while reducing the risk of human error. Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management...
Nasdaq GlobeNewswire
29/10/2025
Electric Wheelchair Market Surges Toward US$ 19.12 Billion by 2033 -- Driven by…
Browse in-depth TOC on ' Electric Wheelchair Market111 - Tables134 - Figures268 - Pages Browse in-depth TOC on ' Electric Wheelchair Market 111 - Tables 134 - Figures 268 - Pages The global electric wheelchair market is driven by a convergence of demographic shifts, technological leaps, and evolving consumer expectations. No longer simply a means of mobility, the modern electric wheelchair is a sophisticated device that offers unprecedented levels of independence, connectivity, and...
PR Newswire
29/10/2025
VUNO Partners with European Firms to Advance DeepCARS® Market Entry in Europe
The MOU was signed on October 27 during a local meeting held in conjunction with the 38th Annual Congress of the European Society of Intensive Care Medicine (ESICM LIVES 2025), which took place from October 25 to 29 in Munich, Germany. Through this agreement, the three companies will collaborate on technical integration, real-world validation, and reimbursement strategies to support the adoption of DeepCARS across European hospitals. The MOU was signed onOctober 27during a local meeting...
PR Newswire
29/10/2025
CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM…
Key Takeaways from the CAR T-cell Therapy Market Report Key Takeaways from the CAR T-cell Therapy Market Report Discover which indication is expected to grab the major CAR T-cell therapy market share @CAR T-cell Therapy Market Report Key Factors Driving the CAR T-cell Therapy Market Large and Growing Unmet Need in Oncology Rising cancer incidence, especially relapsed/refractory hematologic malignancies and an expanding focus on solid-tumor settings, creates a sustained...
PR Newswire
28/10/2025
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting®…
Several posters and presentations featuring new data on three ACLF programs, including G1090N (NTZ reformulation) disease model data, new real-world data and biomarker insights in cirrhosisNew Iqirvo® PBC and PSC data to be presented by partner Ipsen, underscoring its potential in rare cholestatic liver diseases Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), October 28, 2025-GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company...
Nasdaq GlobeNewswire
28/10/2025
DBV Technologies Reports Third Quarter 2025 Financial Results
DBV Technologies Reports Third Quarter 2025 Financial Results DBV closes Q3 2025 with a cash and cash equivalents balance of $69.8 million, taking cash runway into the third quarter of 2026DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company (the "Company"), reported financial results for the third quarter of 2025. The quarterly and nine months unaudited financial statements were approved...
Nasdaq GlobeNewswire
28/10/2025
Electronic Toothbrush Market to Reach USD 6,480.86 million by 2032, Growing At…
Browse the report and understand how it can benefit your business strategy - https://www.credenceresearch.com/report/electronic-toothbrush-market Browse the report and understand how it can benefit your business strategy -https://www.credenceresearch.com/report/electronic-toothbrush-market Market Overview The Electronic Toothbrush Market comprises devices designed to clean teeth using powered bristle movements, offering a more effective and consistent alternative to traditional...
PR Newswire
28/10/2025
Taiwan TCM Pavilion Draws Global Interest at CPHI Frankfurt 2025
Organized by the Department of Chinese Medicine and Pharmacy (DCMP) under Taiwan's Ministry of Health and Welfare (MOHW) and implemented by the Taiwan Institute of Economic Research (TIER), the Pavilion highlights Taiwan's integrated approach to traditional medicine — combining rich clinical heritage, modern scientific validation, and robust regulatory support. Organized by the Department of Chinese Medicine and Pharmacy (DCMP) underTaiwan'sMinistry of Health and Welfare (MOHW) and...
PR Newswire
28/10/2025
IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2025
Aggregated presentation by day and by marketStatement of transactions in own shares from October 20th to October 24th 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1120/10/2025FR0010259150563...
Nasdaq GlobeNewswire
28/10/2025
BASTIDE : 2025-2026 financial calendar
Caissargues, October 28, 2025 Events Dates* 2025-2026 Q1 Revenue Thursday November 13, 2025 2025-2026 H1 Revenue Thursday February 12, 2026 2025-2026 H1 Results Wednesday March 18, 2026 2025-2026 Q3 Revenue Thursday May 14, 2026 2025-2026 Full-Year Revenue Thursday September 3, 2026 2025-2026 Full-Year Results Wednesday October 21, 2026 * Subject…
Actusnews Wire
28/10/2025
ONWARD Medical Publishes Closing of Bookbuild Offering
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)EINDHOVEN, The Netherlands, Oct.28, 2025(GLOBE NEWSWIRE) --...
Nasdaq GlobeNewswire
28/10/2025
Curia Releases 2024 Environmental, Social and Governance (ESG) Report
Key accomplishments from the report include: In 2024, Curia committed to setting near-and long-term company-wide GHG emission reductions in line with climate science through the Science Based Target Initiative (SBTi) and joined the United Nations’ Race to Zero campaign, a global coalition of non-state entities working toward halving global emissions by 2030.Curia’s French facilities in Bon Encontre and Tonneins achieved ISO 9001, 45001 and 14001 certifications, and its sites in Origgio...
Nasdaq GlobeNewswire
28/10/2025
Wound Irrigation System Market to Reach $465.3 million, Globally, by 2034 at…
Request Sample of the Report on Wound Irrigation System Market Forecast 2034 -https://www.alliedmarketresearch.com/request-sample/A43041 Request Sample of the Report on Wound Irrigation System Market Forecast 2034 -https://www.alliedmarketresearch.com/request-sample/A43041 Market Introduction Wound irrigation systems are medical devices designed to deliver a controlled flow of solutions for cleansing wounds, removing debris, and reducing microbial load. They play a critical role...
PR Newswire
28/10/2025
Cell-free Protein Synthesis Market worth $308.9 million by 2030 with 7.3% CAGR |…
Browse in-depth TOC on "Cell-free Protein Synthesis Market" Browse in-depth TOC on "Cell-free Protein Synthesis Market" 400 - Tables 45 - Figures 300 - Pages By offerings,the cell-free protein synthesis market is divided into products (such as expression systems, reagents, and instruments) and services. CFPS services are expected to grow the fastest in the CFPS market during the forecast period, due to their ability to deliver customized protein expression, lower...
PR Newswire
28/10/2025
Glucagon-Like Peptide-1 Analogues Market to Surpass USD 299.08 Billion by 2033…
Market Dynamics: The Dual Impact of Diabetes and Obesity Epidemics Market Dynamics: The Dual Impact of Diabetes and Obesity Epidemics The GLP-1 analogues market is being reshaped by intersecting public health trends- the global rise in obesityand theincreasing prevalence of type 2 diabetes. According to DataM Intelligence, over1 billion people worldwideare now classified as obese, while diabetes affectsover 540 million adults globally, intensifying the need for multi-target...
PR Newswire
28/10/2025
LILYSILK Launches 2025 Black Friday Sale, Celebrating Elegance and Gratitude…
The Worry-Free Wool Skirt redefines woolwear with machine-washable practicality. Designed to flatter all body types, its breathable stretch knit and fluid silhouette offer comfort without compromise and are perfect for office wear or casual elegance. TheWorry-Free Wool Skirtredefines woolwear with machine-washable practicality. Designed to flatter all body types, its breathable stretch knit and fluid silhouette offer comfort without compromise and are perfect for office wear or casual...
PR Newswire
28/10/2025
Script Runner and Uber Direct Partner to Bring Prescription Delivery to Canada
"In rural Alberta, delivery workforce shortages are a constant challenge for pharmacies," said Fayaz Rajabali, franchise owner of three pharmacies and past President of the Alberta College of Pharmacy. "By ensuring it's done properly and within the right regulatory framework, Script Runner's innovative approach with Uber helps us deliver more prescriptions in fewer trips. That means saving time, lowering costs, and ensuring patients receive their medications quickly and reliably…
PR Newswire
28/10/2025
Novartis completes acquisition of Tourmaline Bio
Basel, October 28, 2025- Novartis today announced that it has successfully completed its acquisition of Tourmaline Bio, Inc. (“Tourmaline”). With the completion of the acquisition, shares of common stock, par value $0.0001 per share (the “Shares”), of Tourmaline, have ceased trading on the Nasdaq Stock Market LLC and Tourmaline is now an indirect wholly owned subsidiary of Novartis. “The acquisition of Tourmaline Bio aligns with our strategy to deepen expertise in areas where Novartis can...
Nasdaq GlobeNewswire
28/10/2025
CeraVe Supports Global Skin Health Leaders to Deliver Care to Underserved…
World Skin Health Day is led by the International League of Dermatological Societies (ILDS) and the International Society of Dermatology (ISD). Taking place on 8 July each year, it delivers education on the significance of skin health and encourages discussions and actions that contribute toward improving skin health around the world. As the day's official corporate partner for the second year, CeraVe worked with the ILDS and ISD to build on the achievements of 2024, activating in 9 countries…
PR Newswire
28/10/2025
ALTIUS AND SYD LIFE AI ANNOUNCE $1BN PARTNERSHIP TO TRANSFORM U.S. HEALTHCARE…
Their agreement positions Altius as the exclusive U.S. provider of Syd Life AI's preventive health and life quality technologies, which are already deployed across 26 countries, enabling American employers and the U.S. healthcare system to shift to preventive care. Their agreement positions Altius as the exclusive U.S. provider of Syd Life AI's preventive health and life quality technologies, which are already deployed across 26 countries, enabling American employers and the U.S. healthcare...
PR Newswire
28/10/2025
MAXIMA GRUPĖ redeemed EUR 240 million bond emission
On October 27, MAXIMA GRUPĖ, UAB (hereinafter – MAXIMA GRUPĖ) exercised its early redemption right and redeemed all bonds with a nominal value of EUR 240 million from bondholders. On July 12, 2022, a five-year bond issue with a nominal value of EUR 240 million and a fixed annual interest rate of 6.25% (6.50% annual yield) was distributed. Following the decision to redeem the bonds early, the actual annual yield on the bonds amounted to 8.40%. As previously announced, MAXIMA GRUPĖ has...
Nasdaq GlobeNewswire
28/10/2025
Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to…
This collaboration combines Aji Bio-Pharma's expertise in microbial strain and process development with Olon's large-scale GMP manufacturing expertise utilizing fermenters with a capacity of over 100,000 liters. The partnership will accelerate productive and sustainable manufacturing of high-demand proteins and peptides such as GLP-1 analogs which play a critical role in treating obesity and Type II diabetes. This collaboration combines Aji Bio-Pharma's expertise in microbial strain and…
PR Newswire
28/10/2025
Novo Nordisk to present new Wegovy® (semaglutide 2.4 mg) data at the 2025…
The research to be presented at The Liver Meeting® 2025 reflects Novo Nordisk's leadership in advancing the understanding of optimal screening, diagnosis, and management of MASH and other serious chronic conditions. The research to be presented at The Liver Meeting ®2025 reflects Novo Nordisk's leadership in advancing the understanding of optimal screening, diagnosis, and management of MASH and other serious chronic conditions. Summary of presentationsAccepted data at The Liver Meeting...
PR Newswire
28/10/2025
BioNTech to Host Innovation Series R&D Day on November 11, 2025
MAINZ, Germany, October 28 , 2025 (GLOBE NEWSWIRE)-- BioNTech SE(Nasdaq: BNTX, “BioNTech” or “the Company”), will host an edition of the Company’s Innovation Series R&D Day at 09:00 a.m. Eastern Standard Time (3:00 p.m. CET) on Tuesday, November 11, 2025 in New York City, U.S. On the day, members of BioNTech’s leadership team will provide an overview of the Company’s strategy and clinical progress across its pipeline.Investors, analysts and the interested public are invited to...
Nasdaq GlobeNewswire
28/10/2025
Altri Comunicati
